Fluticasone

Quick links to important sections

Fluticasone

Selected form

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fluticasone

Quick Facts

Property Description
Active ingredient Fluticasone Propionate or Fluticasone Furoate
Form Nasal Spray, Inhalation Powder, Cream, Ointment
Pharmacological Class Corticosteroid, Glucocorticoid
General Purpose Relief from inflammation and swelling
Origin Synthetic Fluorinated Compound

What Type of Medicine is Fluticasone?

Fluticasone is a potent, synthetic fluorinated corticosteroid, definitively classified as a glucocorticoid within the broader corticosteroid pharmacological class. It is an active ingredient that belongs to this group of powerful anti-inflammatory agents. This medication is a man-made compound, designed to mimic the effects of natural glucocorticoid hormones produced by the body. The substance exists primarily as two chemical forms, Fluticasone Propionate and Fluticasone Furoate; both are single-entity compounds, and their synthetic origin contributes to their high efficacy and controlled performance.


Forms and General Purpose of Fluticasone

The compound is manufactured for specific, localized delivery, resulting in several dosage forms including nasal spray, inhalation powder, aerosol, cream, and ointment. The general purpose of Fluticasone is to provide robust anti-inflammatory action and localized immunosuppression to manage symptoms caused by an overactive immune response, such as persistent swelling in the respiratory tract. Due to its intended action, it is categorized as a drug intended for topical administration, whether to mucosal surfaces or the skin. This versatility in presentation ensures the potent compound can be delivered precisely to the affected site, allowing it to relieve generalized swelling and irritation.


Core Distinction: How Fluticasone Works at a High Level

Fluticasone's essential function involves suppressing the body's inflammatory cycle by interfering with cell activity. Its primary mechanism principle is to enter inflammatory cells and inhibit the release of inflammatory mediators, such as cytokines and histamine, which are the chemical signals that trigger and sustain swelling and irritation. This deep-acting ability allows it to modify the entire inflammatory cascade, providing a benefit of actively suppressing the underlying immune overactivity rather than just blocking surface symptoms, establishing its fundamental role as a highly effective anti-inflammatory agent.

Regulatory References

  1. NIH

What side effects are possible with Fluticasone?

Possible Side Effects and Safety Information

Fluticasone is a potent synthetic glucocorticoid, and its safety profile varies based on the formulation (intranasal, inhaled) and duration of use. Adverse reactions are primarily categorized as local or systemic effects.

Common Adverse Reactions

Administration Route Common Reactions (Examples)
Intranasal Epistaxis (nosebleeds), nasal irritation/burning, sore throat, headache.
Inhaled Oropharyngeal candidiasis (thrush), hoarseness/dysphonia, cough, headache.

Serious and Clinically Significant Adverse Reactions

Prolonged use, particularly at higher doses, carries risks associated with systemic corticosteroid exposure:

  • Ocular Effects: The development of glaucoma or cataracts has been reported with long-term use; routine eye examinations may be necessary.
  • HPA Axis Suppression: Hypercorticism and adrenal suppression (Cushing’s syndrome features) are potential risks, especially when transitioning from systemic corticosteroids or when used with strong CYP3A4 inhibitors (like ritonavir), which significantly increase fluticasone exposure. Co-administration with ritonavir is generally avoided.
  • Immunosuppression: Fluticasone can increase susceptibility to and worsen the course of existing infections (e.g., tuberculosis, ocular herpes simplex). Non-immune individuals exposed to chickenpox or measles may face a more severe course of illness.
  • Local Nasal Damage: Nasal septal perforation and nasal ulceration have been reported in postmarketing surveillance for intranasal formulations.

Population-Specific Safety Considerations

  • Children and Adolescents: Growth retardation has been observed in pediatric patients using nasal corticosteroids; height should be regularly monitored.
  • Contraindications: Use is contraindicated in patients with a known hypersensitivity to fluticasone or any component of the formulation.
  • Limitations: Caution is required in patients with recent nasal surgery, trauma, or unhealed nasal sores due to the potential for impaired wound healing.

Overdose and Emergency Response

Overdose with fluticasone is primarily a risk associated with chronic use of excessive doses rather than a single acute event. Prolonged overexposure can lead to documented systemic glucocorticoid effects, resulting in the official regulatory manifestation of Hypercorticism and the underlying physiological finding of Hypothalamic-Pituitary-Adrenal (HPA) axis suppression.

The most severe and potentially life-threatening outcome documented in regulatory labeling is Acute Adrenal Insufficiency. This serious condition can be precipitated by physiological stress, such as trauma, severe illness, or surgery, in individuals whose HPA axis has been suppressed by high-dose fluticasone over-treatment.

Immediate medical help is required if HPA axis suppression is suspected or if symptoms of acute adrenal insufficiency arise during stress. Regulatory documentation confirms there is no specific antidote for fluticasone overdose. The official management protocol for chronic overexposure requires the slow and careful discontinuation of the medication under medical supervision to allow adrenal function to gradually recover. For the pediatric population, the systemic effects necessitate routine growth monitoring due to the documented risk of growth retardation.

Therapeutic Uses of Fluticasone

What Fluticasone Treats: Main Uses and Benefits


Fluticasone is commonly used across domains where additional symptomatic support is needed to manage symptoms related to inflammatory or irritative states. It is applied in contexts where short-term symptom management is appropriate in conditions presenting with systemic or localized discomfort.

The medication is relevant for easing symptoms associated with allergic and chronic rhinitis (seasonal and perennial allergies), is commonly used across conditions presenting with episodic or fluctuating manifestations like asthma in the airways, and for localized symptomatic relief in inflammatory skin conditions such as eczema and psoriasis. It is applied in addressing symptom clusters that may become intense or disruptive, including persistent sneezing, nasal congestion, itching, wheezing, and skin redness.

This provides support that helps ease the overall symptom burden, particularly during episodic or fluctuating manifestations, and may assist with maintaining functional stability.


Quick Fact: Nasal Congestion Symptom Support

The medication is relevant for easing symptoms related to physical discomfort, commonly used when short-term symptomatic assistance is needed to help with daily functioning.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

The eligibility for Fluticasone use is strictly defined by official regulatory documentation (e.g., FDA, EMA) based on population characteristics and pre-existing conditions.

Contraindicated Populations

Fluticasone is contraindicated for any patient with a known hypersensitivity or allergy to fluticasone or any excipient in the product. Inhaled formulations must not be used for the primary treatment of acute episodes of asthma or status asthmaticus.

Restricted or Conditional Use

Use requires special consideration in patients with certain pre-existing infections, including active or quiescent tuberculosis, or systemic fungal, bacterial, or viral infections. Patients with a history of glaucoma or cataracts warrant close monitoring. For nasal formulations, use is discouraged until healing is complete in patients with recent nasal trauma, surgery, or ulcers.

Age-Related Eligibility

The minimum eligible age varies by formulation: some nasal and inhaled products are approved for patients aged 4 years and older, while others may be restricted to ages 6 or 12 years and older. Safety and efficacy are generally not established in children younger than the specified age limit. For topical use, caution is advised and use should be avoided in infants younger than 1 year.

Pregnancy and Lactation Status

Fluticasone is generally recommended only if the benefit is determined to outweigh the potential risk during pregnancy, as human data is often insufficient to fully assess risk. Minimal systemic absorption suggests a low risk during breastfeeding, but a medical assessment is required.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The officially documented interactions with Fluticasone primarily involve its metabolic clearance pathway. Fluticasone is defined as a substrate of the Cytochrome P450 3A4 (CYP3A4) isoenzyme, which is the enzyme responsible for clearing the medicine from systemic circulation via hepatic metabolism. Interactions arise when co-administering potent inhibitors of this enzyme.

Documented Pharmacokinetic Interactions

The coadministration of Fluticasone with the highly potent CYP3A4 inhibitor Ritonavir is not recommended. This restriction is documented because the combination may significantly increase Fluticasone's systemic exposure, leading to the risk of systemic corticosteroid effects, including hypercorticism and adrenal suppression.

Similarly, co-use with other strong CYP3A4 inhibitors, such as Ketoconazole, is also officially noted to increase systemic exposure and reduce plasma cortisol levels. This pharmacokinetic alteration dictates that caution is required with the entire class of strong inhibitors.

Other Interaction Constraints

Consumption of Grapefruit Juice is noted to increase systemic Fluticasone exposure due to its established effect as a strong CYP3A4 inhibitor. Furthermore, patients with severe hepatic impairment may experience increased systemic exposure to the Fluticasone Furoate form, as reduced liver function impairs its metabolic clearance.

Mechanism of Action

The action of Fluticasone is defined by its selective and high-affinity interaction with the Glucocorticoid Receptor ( GR) within target cells, engaging core mechanisms that modulate inflammatory processes. The compound penetrates the cell membrane to reach the GR, initiating a cascade of genetic modulation that fundamentally alters the cell’s inflammatory state.

Fluticasone acts as an agonist that binds to the GR, activating the receptor complex which then moves into the nucleus. This complex engages mechanisms that regulate the activity of Glucocorticoid Response Elements ( GREs) on the DNA. The primary physiological effect stems from Transrepression, where the activated GR complex physically suppresses key pro-inflammatory transcription factors, notably Nuclear Factor-kappa B ( NF-kappa B). By shutting down these master regulators, Fluticasone halts the synthesis and release of cytokines and chemokines, which typically mediate inflammatory cell migration and fluid accumulation.

Due to the reliance on gene transcription, the full physiological profile builds up progressively, giving its action a delayed onset profile over several days or weeks. Furthermore, the mechanism can be constrained where essential co-factors (like HDAC2) are impaired by oxidative stress, reducing the extent of the anti-inflammatory modulation.

Dosage and Administration Information

Administration Overview

Fluticasone is typically administered through specific delivery systems designed to target different areas of the body, such as the nasal passages or the respiratory tract. The effectiveness of the medication depends on consistent application and the use of the correct technique associated with the specific device provided.

Nasal Spray Application

When used for nasal symptoms, fluticasone is delivered via a metered-spray bottle. Preparation usually involves shaking the container gently to ensure the suspension is well-mixed. The device often requires priming if it has not been used recently, which involves spraying the medication into the air until a fine mist appears.

During application, the head is typically tilted slightly forward. The nozzle is inserted into a nostril, aiming toward the outer side of the nose rather than the middle septum. While breathing in through the nose, the pump is depressed once. This process is then repeated for the other nostril as required.

Inhalation Technique

For respiratory conditions, fluticasone is administered using a metered-dose inhaler (MDI) or a dry powder inhaler (DPI).

  • Metered-Dose Inhalers: These devices use a pressurized canister. Proper use involves exhaling fully before placing the mouthpiece in the mouth. As the canister is pressed to release the medication, a slow, deep breath is taken. Holding the breath for several seconds afterward allows the medication to settle in the airways.
  • Dry Powder Inhalers: Unlike MDIs, these devices are breath-activated and do not require coordination between pressing a canister and inhaling. A quick, deep inhalation is necessary to draw the powder from the device into the lungs.

Post-Inhalation Care

After using an oral inhaler, it is standard practice to rinse the mouth with water and spit it out. This helps remove any residual medication from the oral cavity and throat surfaces.

Maintenance and Storage

To ensure the delivery systems function correctly, the spray nozzles or inhaler mouthpieces should be cleaned regularly according to the manufacturer's guidelines. The medication should be stored at room temperature, away from direct heat, moisture, and sunlight. Canisters used in MDIs should be kept away from open flames, as they are pressurized.

Recent Clinical Evidence

Research evidence / Overview of Studies for Fluticasone

Evidence for Use in Managing Chronic Asthma

Research on inhaled Fluticasone has been conducted using numerous Randomized Controlled Trials (RCTs) and Systematic Reviews. These studies focused primarily on adults and children with persistent asthma, with research examining how symptoms change over time. Studies monitored outcomes related to physiological strain, specifically measuring changes in lung function tests (like FEV1) and the frequency of asthma exacerbations. The findings from these trials describe patterns observed in the studies related to lung function measurements over time. Research explored whether there was an association with a measured reduction in the required daily oral steroid dose in severe asthma populations. Results apply only to the populations studied, and data are still emerging regarding the comparative effect of different inhaled Fluticasone doses in patients with very mild asthma.

Evidence for Use in Allergic Rhinitis (Nasal Allergies)

Intranasal Fluticasone has been evaluated in short-term and medium-term RCTs involving patients diagnosed with seasonal and perennial allergies. Research examined outcomes linked to inflammatory or irritative states by measuring combined symptom scores for persistent nasal and ocular symptoms. Trials reported that the symptom scores measured during the study period were typically different from the scores recorded for patients using a placebo spray. Research also examined outcomes when compared to other allergy medications. Limited information exists for long-term outcomes regarding continuous use extending beyond one year.

Evidence for Use in Inflammatory Skin Conditions

The evidence for topical Fluticasone involves RCTs applied in research contexts involving fluctuating symptoms of corticosteroid-responsive skin conditions, such as eczema. Research examined outcomes related to physical discomfort, primarily focusing on the reduction of scaling, inflammation, and itching (pruritus). Studies reported measurements that were different from the vehicle (inactive base) in some trials. Research limitations include limited follow-up durations, meaning long-term effects on the skin are not clearly established in the available short-term trials.

What Remains Unclear or Under Study

Research highlights areas where certainty remains low or where more research is needed. One area involves the precise comparative effects across different formulations and delivery devices. Furthermore, evidence quality varies across studies, leading to statistical variability in pooled research. Long-term effects are not fully established for some outcomes, and while many studies exist, research provides insight into short-term changes, but long-term effects are often less detailed.

Key Studies & References

  1. Fluticasone in mild to moderate atopic dermatitis relapse: A randomized controlled trial - Elsevier

Frequently Asked Questions (FAQ)

Common questions about Fluticasone (FAQ)


Q: What is the difference between Fluticasone and other similar nose sprays?

Fluticasone is classified in regulatory documents as a corticosteroid, which is a type of steroid with potent anti-inflammatory activity. Unlike short-term decongestants, it works by reducing the underlying inflammatory response over time. This mechanism of action represents its core classification difference compared to non-steroid nasal sprays.

Q: Why do people use Fluticasone long-term?

Official product information indicates that Fluticasone is used for the maintenance treatment of chronic conditions, such as perennial allergic rhinitis or asthma. Scheduled daily use is typically required to achieve and sustain symptom control, as the medication works progressively rather than instantly.

Q: Can Fluticasone be used for congestion that is not from allergies?

Regulatory documents explicitly list Fluticasone Propionate as being indicated for managing nasal symptoms of perennial nonallergic rhinitis in certain patient groups. Nonallergic rhinitis is inflammation in the nose that is not triggered by typical allergens like pollen or dust.

Q: Is Fluticasone known to cause weight gain?

Regulatory data indicates that weight gain has been reported as a rare or uncommonly observed side effect. This is sometimes described as being linked to the risk of systemic corticosteroid effects, which can occur if the medication is absorbed into the bloodstream.

Q: Is Fluticasone the same as Flonase or other brand names?

Fluticasone (propionate or furoate) is the active ingredient or established name of the medicine. Flonase is one of the proprietary brand names used for products containing this active ingredient. Many products containing fluticasone are available under various brand names and as generic versions.

Q: Do I need a prescription to get Fluticasone?

The legal status of Fluticasone varies by country and formulation. For example, in some countries, Fluticasone Propionate nasal spray is available in both Over-the-Counter (OTC) and prescription versions, depending on the dose or strength.

Q: Does Fluticasone make you drowsy or tired?

Regulatory adverse reactions sections do not commonly list drowsiness. However, unusual tiredness or weakness (fatigue/malaise) is cited as a reported side effect, particularly in relation to possible hormonal effects.

Q: Can Fluticasone affect my sense of smell or taste?

Official information and post-marketing reports indicate that a change in how things taste or smell is a possible side effect of nasal fluticasone products.

Q: Can Fluticasone be used with other allergy pills?

Specific interaction warnings for common oral antihistamines are not usually listed in regulatory documentation. However, official guidelines suggest informing a healthcare provider of all medications being taken, as potential side effects may be amplified.

Q: Does Fluticasone interact with cold or flu medicines?

Fluticasone typically has no known interaction with common cold ingredients like acetaminophen. Caution is advised with cold medicines containing sympathomimetic agents (such as pseudoephedrine), which carry separate cardiovascular warnings. These warnings are present in official documentation regarding concurrent medications.

Q: Can Fluticasone be used by people with high blood pressure?

Regulatory documents note that the use of steroids can rarely cause or aggravate hypertension (high blood pressure). Official guidelines indicate that the use of the lowest effective dose is an important consideration.

Q: Do older adults (seniors) need to take special precautions with Fluticasone?

Regulatory labels state that dose selection for an elderly patient should be cautious, due to the greater likelihood of decreased organ function. This often involves considerations for a lower end of the dosing range.

Q: Why is Fluticasone sometimes used to treat nasal polyps?

Fluticasone Propionate, often in specific delivery forms, is FDA-indicated for the treatment of nasal polyps in adult patients. Nasal polyps are non-cancerous growths in the nose or sinuses often associated with chronic inflammation.

Q: What is the main difference in how Fluticasone works compared to decongestants?

Fluticasone is a corticosteroid that works over days or weeks by suppressing the release of inflammatory mediators within the cells. Decongestants, by contrast, work rapidly by constricting blood vessels to temporarily reduce swelling and are not pharmacologically classified as anti-inflammatory agents.

Q: Does Fluticasone affect sleep?

The official product information, such as the EMA SmPC, lists sleep disorders as a very rare psychiatric adverse reaction that has been reported, predominantly in children.

Q: What does 'systemic absorption' mean in relation to Fluticasone nasal spray?

Systemic absorption refers to the small amount of drug that enters the bloodstream (systemic circulation) after administration. Regulatory reports indicate that systemic absorption is generally very low for the nasal spray form, indicating that the majority of the substance acts locally at the site of administration.

Q: Can Fluticasone interact with supplements or herbal remedies?

Sufficient information is generally not available on the safety of using herbal remedies and supplements with Fluticasone. Official safety guidance suggests discussing these products with a healthcare provider, particularly if the supplements are known to affect liver enzymes.

Q: Does Fluticasone interact with alcohol?

Alcohol is generally not known to interact with or be a contraindication for Fluticasone use. Official guidelines do not list a specific alcohol restriction.

Q: Is it described as a controlled substance in any official documents?

Fluticasone is generally listed as having No DEA Schedule in the United States, meaning it is not classified as a federally controlled substance by the Drug Enforcement Administration (DEA).

Q: Is a bitter taste in the back of the throat a common effect of Fluticasone nasal spray?

A change in how things taste (including a bitter taste) is listed as a possible side effect of the nasal spray form. It is often a local effect, and correct administration technique is used to help minimize this occurrence.

Q: Are there any known issues with Fluticasone and dental health?

Oropharyngeal candidiasis (thrush), a yeast infection in the mouth or throat, is a common side effect of inhaled forms of Fluticasone. Additionally, some literature suggests that long-term use of high-potency corticosteroids may have effects on bone mineral density in the jaw that warrant consideration.

Q: Is there a generic version of Fluticasone available?

Yes, regulatory records show that generic versions of Fluticasone Propionate and Fluticasone Furoate in various forms are widely authorized and marketed, alongside brand-name products.

Q: Can Fluticasone interact with medications for mental health conditions?

No general interaction is typically listed in official warnings. However, caution is advised because some medications for mental health, such as SSRI antidepressants, can affect eye pressure, and corticosteroids carry independent warnings for eye conditions like glaucoma.

Q: Is a runny nose considered a common side effect of Fluticasone?

While Fluticasone treats a runny nose caused by allergies, an increase in runny nose may be reported as a symptom of a general adverse reaction. Official documents list this symptom under reported side effects such as upper respiratory tract infection or inflammation.

Q: What should I do if I get Fluticasone spray in my eyes?

Regulatory guidance specifies to avoid spraying into the eyes. Regulatory guidance states that if accidental contact occurs, the area should be rinsed with water immediately.

Q: How long can I continue to use Fluticasone safely?

There is no specific maximum duration limit when the drug is used at recommended doses for chronic conditions. However, long-term use requires periodic monitoring by a healthcare provider for potential systemic effects, such as eye issues or effects on growth in children.

How should Fluticasone be stored and disposed of?

How to Store and Dispose of Fluticasone

Official regulatory documents define strict requirements for storing and disposing of fluticasone, which vary slightly by formulation.

Fluticasone propionate nasal spray must be stored at Controlled Room Temperature, specifically between 4 C and 30 C (39 F and 86 F) in its original container.

Fluticasone furoate nasal spray has distinct rules: it must not be refrigerated or frozen, should be stored upright, and has a stability limit of 2 months after first opening. All fluticasone products must be kept out of the sight and reach of children.

Expired or unused product must be handled as pharmaceutical waste and disposed of according to local regulations. It is strictly required that the medicine not be discarded in household waste or wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fluticasone found in:

A-Z Index: